NM
PYXS icon

Newtyn Management’s Pyxis Oncology PYXS Stock Holding History

Newtyn Management’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,500,000
Closed -$2.01M – 82
2022
Q4 		$2.01M Buy
1,500,000
+700,000
+88% +$1.05M 0.41% 38
2022
Q3 		$1.58M Hold
800,000
– – 0.35% 43
2022
Q2 		$1.9M Buy
+800,000
New +$2.13M 0.36% 43

Other funds holding PYXS

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Newtyn Management's PYXS Position: Q1 2023 in Review

Newtyn Management sold out of Pyxis Oncology (PYXS) in Q1 2023, closing a stake of 1,500,000 shares — an estimated $2.01M sold.

Newtyn Management first reported a position in PYXS in Q2 2022 and held it in 3 quarters. The position peaked at $2.01M in Q4 2022. 47 funds tracked by Wall St. Rank hold PYXS as of Q1 2023.

  • Newtyn Management reported no remaining Pyxis Oncology position as of Q1 2023 after selling out during the quarter.
  • Newtyn Management sold 1,500,000 Pyxis Oncology shares in Q1 2023, an estimated $2.01M.
  • Newtyn Management first reported a position in Pyxis Oncology in Q2 2022 and held it in 3 quarters.
  • Newtyn Management's Pyxis Oncology position peaked at $2.01M in Q4 2022.
  • 47 funds tracked by Wall St. Rank held Pyxis Oncology as of Q1 2023.

Based on Newtyn Management's 13F filing for Q1 2023, filed 15 May 2023.